[Serum cellular inflammatory markers in the diagnosis of prostate cancer.]
Prostate cancer (PCa) is one of the most frequent neoplasms in the masculine sex, which has multiple etiological factors, inflammation is one of them. To determine the role of different inflammatory markers in the diagnosis of PCa in first prostatic biopsies. This is a prospective study evaluating neutrophil/ lymphocyte (NLR), neutrophil/monocyte (NMR) and platelet/lymphocyte (PLR) ratios of 78 patients with suspected PCa due to PSA alteration and/or abnormal digital rectal examination, and its correlation with twelve-cylinder biopsy result. The NLR, NMR and PLR were all higher in the group diagnosed with PCa compared to the group with benign prostatic hyperplasia (p > 0.05). Inflammatory markers can be predictive factors in the diagnosis of PCa, although more studies are needed for their routine use.